Story

NuvOx Therapeutics Files for NYSE American IPO with Proposed Price of $6 to $8

ENTHMSVIIDZHZH-TWJAKOHI
Jul 17, 20261 min read
NuvOx Therapeutics Files for NYSE American IPO with Proposed Price of $6 to $8

Summary

The company plans to list its common stock under the ticker symbol NUOX, with ThinkEquity serving as the underwriter for the initial public offering.

Text size
Background

NuvOx Therapeutics, Inc. has filed for an initial public offering of its common stock, signaling its intent to become a publicly traded company. The firm plans to list its shares on the NYSE American exchange under the proposed ticker symbol NUOX.

Offering Details

According to a company press release, the proposed IPO sets an anticipated price range of $6.00 to $8.00 per share. Prior to this filing, there has been no public market for NuvOx Therapeutics' common stock.

Key details of the planned offering include:

  • Exchange: NYSE American
  • Ticker Symbol: NUOX
  • Proposed Price Range: $6.00 - $8.00 per share
  • Underwriter: ThinkEquity
Sample IUX Markets – In-articleAd

Market Debut and Context

The offering is contingent upon final approval from the exchange. As the sole underwriter, ThinkEquity will manage the process of bringing the company's shares to market.

An initial public offering is a significant step for a private company, allowing it to raise capital from public investors to fund operations, research, or expansion. The final pricing and success of the IPO will depend on investor appetite and broader market conditions at the time of the listing.

Read next

More on Stocks
Back to latest news

LATEST